New phenalenone analogues with improved activity against Leishmania species

• Main Authors: Atteneri López-Arencibia, Carlos J. Bethencourt-Estrella, Mónica B. Freijo, María Reyes-Batlle, Ines Sifaoui, Desirée San Nicolás-Hernández, Grant McNaughton-Smith, Jacob Lorenzo-Morales, Teresa Abad-Grillo, José E. Piñero
• Format: Article
• Language: English
• Published: Elsevier 2020-12-01
• Series: Biomedicine & Pharmacotherapy
• Subjects: Phenalenones; Leishmania amazonensis; apoptosis-like; chemotherapy
• Online Access: http://www.sciencedirect.com/science/article/pii/S0753332220310076

ABSTRACT: The in vitro activity against Leishmania spp. of five novel designed compounds, phenalenone derivatives, is described in this study. Previous works have shown that some phenalenones present leishmanicidal activity, some of which could induce programmed cell death events in L. amazonensis parasites. In this research, we focused on the determination of the programmed cell death evidence by detecting the characteristic features of the apoptosis-like process, such as phosphatidylserine exposure and mitochondrial membrane potential, among others. The results showed that the new derivatives have comparable or better activity and selectivity than the commonly prescribed anti-leishmanial drug. This result was obtained by inducing stronger mitochondrial depolarization or more intense phosphatidylserine exposure than miltefosine, highlighting compound 8 with moreover 9-times better selectivity index. In addition, the new five molecules activated the apoptosis-like process in the parasite. All the signals observed were indicative of the death process that the parasites were undergoing.